AbCellera to Participate Virtually in the Truist Securities AI Symposium – Biotech & Tools
February 23 2022 - 4:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will participate in a panel during the Truist
Securities AI Symposium – Biotech & Tools. The panel is titled,
“Integrated Platforms for AI-based Drug Discovery,” and will take
place virtually on Tuesday, March 1, 2022, at 8:20 a.m. Pacific
Time.
A live audio webcast of the panel may be accessed through a link
that will be posted on AbCellera's Investor Relations website. A
replay will be available through the same link following the
presentation.
About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and
analyzes natural immune systems to find antibodies that its
partners can develop into drugs to prevent and treat disease.
AbCellera partners with drug developers of all sizes, from large
pharmaceutical to small biotechnology companies, empowering them to
move quickly, reduce costs, and tackle the toughest problems in
drug development. For more information, please visit
www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220223006146/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Neil
Berkley; bd@abcellera.com, +1(604)559-9005 Investor Relations:
Melanie Solomon; ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Apr 2023 to Apr 2024